FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022700706> ?p ?o ?g. }

• W2022700706 endingPage "26158" @default.
• W2022700706 startingPage "26152" @default.
• W2022700706 abstract "The cDNA encoding a novel P2 receptor was isolated from rat aortic smooth muscle cell library and functionally characterized. The cloned P2 receptor exhibits structural features characteristic of the G protein-coupled receptor family and shows 44 and 38% amino acid identity with previously cloned rat P2U and chicken P2Y receptors, respectively. The cloned P2 receptor is functionally coupled to phospholipase C but not to adenylate cyclase in C6 rat glioma cells transfected with the cloned P2 expression vector. The rank order of agonist potency as judged by intracellular Ca2+ mobilization responses is UTP > ADP = 2-methylthioATP > ADPβS > ATP = ATPγS, which is not compatible with any of the previously characterized P2 receptor subtypes. The nonselective P2 antagonists, suramin and reactive blue-2, inhibit nucleotide-induced phospholipase C activation in cells expressing the cloned P2 receptor. The cloned P2 receptor mRNA is abundantly expressed in various rat tissues including lung, stomach, intestine, spleen, mesentery, heart, and, most prominently, aorta. The results indicate that the novel metabotropic P2 receptor has pharmacological characteristics distinct from any of P2 receptor subtypes thus far identified and suggest the existence of a novel regulatory system by extracellular nucleotides of potential significance. The cDNA encoding a novel P2 receptor was isolated from rat aortic smooth muscle cell library and functionally characterized. The cloned P2 receptor exhibits structural features characteristic of the G protein-coupled receptor family and shows 44 and 38% amino acid identity with previously cloned rat P2U and chicken P2Y receptors, respectively. The cloned P2 receptor is functionally coupled to phospholipase C but not to adenylate cyclase in C6 rat glioma cells transfected with the cloned P2 expression vector. The rank order of agonist potency as judged by intracellular Ca2+ mobilization responses is UTP > ADP = 2-methylthioATP > ADPβS > ATP = ATPγS, which is not compatible with any of the previously characterized P2 receptor subtypes. The nonselective P2 antagonists, suramin and reactive blue-2, inhibit nucleotide-induced phospholipase C activation in cells expressing the cloned P2 receptor. The cloned P2 receptor mRNA is abundantly expressed in various rat tissues including lung, stomach, intestine, spleen, mesentery, heart, and, most prominently, aorta. The results indicate that the novel metabotropic P2 receptor has pharmacological characteristics distinct from any of P2 receptor subtypes thus far identified and suggest the existence of a novel regulatory system by extracellular nucleotides of potential significance." @default.
• W2022700706 created "2016-06-24" @default.
• W2022700706 creator A5019617623 @default.
• W2022700706 creator A5058121331 @default.
• W2022700706 creator A5059707908 @default.
• W2022700706 creator A5068324001 @default.
• W2022700706 date "1995-11-01" @default.
• W2022700706 modified "2023-10-12" @default.
• W2022700706 title "Molecular Cloning and Functional Analysis of a Novel P2 Nucleotide Receptor" @default.
• W2022700706 cites W1504478980 @default.
• W2022700706 cites W1563725780 @default.
• W2022700706 cites W1588320719 @default.
• W2022700706 cites W1815757713 @default.
• W2022700706 cites W1878565906 @default.
• W2022700706 cites W1945199177 @default.
• W2022700706 cites W1965201236 @default.
• W2022700706 cites W1966910408 @default.
• W2022700706 cites W1973822015 @default.
• W2022700706 cites W1975304761 @default.
• W2022700706 cites W1995134828 @default.
• W2022700706 cites W2001702262 @default.
• W2022700706 cites W2001789263 @default.
• W2022700706 cites W2004516283 @default.
• W2022700706 cites W2009935511 @default.
• W2022700706 cites W2013450910 @default.
• W2022700706 cites W2021184142 @default.
• W2022700706 cites W2021907259 @default.
• W2022700706 cites W2022468880 @default.
• W2022700706 cites W2023204231 @default.
• W2022700706 cites W2030204779 @default.
• W2022700706 cites W2030725821 @default.
• W2022700706 cites W2035971243 @default.
• W2022700706 cites W2038602542 @default.
• W2022700706 cites W2078323484 @default.
• W2022700706 cites W2079752840 @default.
• W2022700706 cites W2083164222 @default.
• W2022700706 cites W2084858489 @default.
• W2022700706 cites W2089193539 @default.
• W2022700706 cites W2094428264 @default.
• W2022700706 cites W2096977013 @default.
• W2022700706 cites W2116949924 @default.
• W2022700706 cites W2123382745 @default.
• W2022700706 cites W2141260882 @default.
• W2022700706 cites W2283946947 @default.
• W2022700706 cites W4294216491 @default.
• W2022700706 doi "https://doi.org/10.1074/jbc.270.44.26152" @default.
• W2022700706 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7592819" @default.
• W2022700706 hasPublicationYear "1995" @default.
• W2022700706 type Work @default.
• W2022700706 sameAs 2022700706 @default.
• W2022700706 citedByCount "236" @default.
• W2022700706 countsByYear W20227007062012 @default.
• W2022700706 countsByYear W20227007062013 @default.
• W2022700706 countsByYear W20227007062014 @default.
• W2022700706 countsByYear W20227007062015 @default.
• W2022700706 countsByYear W20227007062016 @default.
• W2022700706 countsByYear W20227007062017 @default.
• W2022700706 countsByYear W20227007062018 @default.
• W2022700706 countsByYear W20227007062019 @default.
• W2022700706 countsByYear W20227007062020 @default.
• W2022700706 countsByYear W20227007062021 @default.
• W2022700706 crossrefType "journal-article" @default.
• W2022700706 hasAuthorship W2022700706A5019617623 @default.
• W2022700706 hasAuthorship W2022700706A5058121331 @default.
• W2022700706 hasAuthorship W2022700706A5059707908 @default.
• W2022700706 hasAuthorship W2022700706A5068324001 @default.
• W2022700706 hasBestOaLocation W20227007061 @default.
• W2022700706 hasConcept C104317684 @default.
• W2022700706 hasConcept C116016267 @default.
• W2022700706 hasConcept C135285700 @default.
• W2022700706 hasConcept C153911025 @default.
• W2022700706 hasConcept C160225129 @default.
• W2022700706 hasConcept C170493617 @default.
• W2022700706 hasConcept C17971392 @default.
• W2022700706 hasConcept C187882448 @default.
• W2022700706 hasConcept C189482833 @default.
• W2022700706 hasConcept C2778597717 @default.
• W2022700706 hasConcept C55493867 @default.
• W2022700706 hasConcept C57306754 @default.
• W2022700706 hasConcept C75184817 @default.
• W2022700706 hasConcept C86803240 @default.
• W2022700706 hasConceptScore W2022700706C104317684 @default.
• W2022700706 hasConceptScore W2022700706C116016267 @default.
• W2022700706 hasConceptScore W2022700706C135285700 @default.
• W2022700706 hasConceptScore W2022700706C153911025 @default.
• W2022700706 hasConceptScore W2022700706C160225129 @default.
• W2022700706 hasConceptScore W2022700706C170493617 @default.
• W2022700706 hasConceptScore W2022700706C17971392 @default.
• W2022700706 hasConceptScore W2022700706C187882448 @default.
• W2022700706 hasConceptScore W2022700706C189482833 @default.
• W2022700706 hasConceptScore W2022700706C2778597717 @default.
• W2022700706 hasConceptScore W2022700706C55493867 @default.
• W2022700706 hasConceptScore W2022700706C57306754 @default.
• W2022700706 hasConceptScore W2022700706C75184817 @default.
• W2022700706 hasConceptScore W2022700706C86803240 @default.
• W2022700706 hasIssue "44" @default.
• W2022700706 hasLocation W20227007061 @default.
• W2022700706 hasOpenAccess W2022700706 @default.

• next